TRAVOCORT NERISONE FORTE NERISONE FORTE NERISONE-C NERISONE-C NERISONE FATTY NERISONE FATTY NERISONE NERISONE NERISONE NERISONE DIFLODERM DIFROSONE FORTE DIFROSONE FORTE DEFLOCORT ACORT ETRIN VALSOZOL LYNA PEVADERM-D DIVICON CORTICOZOLE DIFZOLE BRAVOCORT AF

Dose: 0.1 to 0.3 %
Single Dose: 0.2 (0.2)
Frequency: 8 hourly
Route: Topical
Instructions: Initial

Dose: SA
Single Dose:
Frequency:
Route:
Instructions:

. It is of Synthetic origin and belongs to Cortiocosteroid. It belongs to Dermatological Products and Corticosteroid Topical pharmacological group.The Molecular Weight of Diflucortolone (Valerate) is 478.60.

Diflucortolone (Valerate) is contraindicated in conditions like Viral infection,Syphilis,Tuberculosis.

The severe or irreversible adverse effects of Diflucortolone (Valerate), which give rise to further complications include Telangiectasia.The symptomatic adverse reactions produced by Diflucortolone (Valerate) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Acneform, Perioral dermatitis, Skin atrophy, Hypertrichosis, Gingival hypertrophy.

Diflucortolone (Valerate) is primarily indicated in conditions like Burns, Contact dermatitis, Contact eczema, Erythrasma, Folliculitis, Impetigo, Insect bites, Lupus erythematosus discoides, Seborrhoic eczema, Sunburn.

No data regarding the interactions of Diflucortolone (Valerate) was found.

Drug should not be given to Paediatrics, Pregnant Mothers, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Store Below 40°C. Protect from Sunlight. Cream, Oint Store Below 25°C.

If rosacea or perioral dermatitis is present, the preparations must not be applied to the face. The preparations should not be allowed to come into contact with the eyes when being applied to the face. Under protracted use, the cream can dry out the skin.